Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1114830-16-8 | MDL No. : | MFCD16036588 |
Formula : | C10H13BrN2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | XSBAGLHOIWJHJW-UHFFFAOYSA-N |
M.W : | 273.13 | Pubchem ID : | 53419965 |
Synonyms : |
|
Num. heavy atoms : | 15 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.5 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 60.06 |
TPSA : | 52.08 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.76 cm/s |
Log Po/w (iLOGP) : | 2.7 |
Log Po/w (XLOGP3) : | 1.7 |
Log Po/w (WLOGP) : | 2.12 |
Log Po/w (MLOGP) : | 1.27 |
Log Po/w (SILICOS-IT) : | 2.43 |
Consensus Log Po/w : | 2.04 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.64 |
Solubility : | 0.631 mg/ml ; 0.00231 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.41 |
Solubility : | 1.07 mg/ml ; 0.0039 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.81 |
Solubility : | 0.0425 mg/ml ; 0.000156 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.14 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 1134327-91-5 ]
Ethyl 2-(5-bromopyrimidin-2-yl)acetate
Similarity: 0.94
[ 1134327-93-7 ]
2-(5-Bromopyrimidin-2-yl)acetic acid
Similarity: 0.84
[ 1447607-69-3 ]
Methyl 1-(5-bromopyrimidin-2-yl)cyclopropanecarboxylate
Similarity: 0.83
[ 185030-22-2 ]
Ethyl 2-(5-bromopyrimidin-4-yl)acetate
Similarity: 0.71
[ 1235450-86-8 ]
5-Bromo-2-ethylpyrimidine-4-carboxylic acid
Similarity: 0.67
[ 1134327-91-5 ]
Ethyl 2-(5-bromopyrimidin-2-yl)acetate
Similarity: 0.94
[ 1447607-69-3 ]
Methyl 1-(5-bromopyrimidin-2-yl)cyclopropanecarboxylate
Similarity: 0.83
[ 63155-11-3 ]
Ethyl 2-(pyrimidin-2-yl)acetate
Similarity: 0.81
[ 164296-40-6 ]
Diethyl 2-(pyrimidin-2-yl)malonate
Similarity: 0.75
[ 1134327-91-5 ]
Ethyl 2-(5-bromopyrimidin-2-yl)acetate
Similarity: 0.94
[ 1134327-93-7 ]
2-(5-Bromopyrimidin-2-yl)acetic acid
Similarity: 0.84
[ 1447607-69-3 ]
Methyl 1-(5-bromopyrimidin-2-yl)cyclopropanecarboxylate
Similarity: 0.83
[ 63155-11-3 ]
Ethyl 2-(pyrimidin-2-yl)acetate
Similarity: 0.81